HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice.

Abstract
Like other antihuman immunodeficiency virus dideoxynucleosides, stavudine may occasionally induce lactic acidosis and perhaps lipodystrophy in metabolically or genetically susceptible patients. We studied the effects of stavudine on mitochondrial DNA (mtDNA), fatty acid oxidation, and blood metabolites in lean and genetically obese (ob/ob) mice. In lean mice, mtDNA was depleted in liver and skeletal muscle, but not heart and brain, after 6 weeks of stavudine treatment (500 mg/kg/day). With 100 mg/kg/day, mtDNA transiently decreased in liver, but was unchanged at 6 weeks in all organs, including white adipose tissue (WAT). Despite unchanged mtDNA levels, lack of significant oxidative mtDNA lesions (as assessed by long polymerase chain reaction experiments), and normal blood lactate/pyruvate ratios, lean mice treated with stavudine for 6 weeks had increased fasting blood ketone bodies, due to both increased hepatic fatty acid beta-oxidation and decreased peripheral ketolysis. In obese mice, basal WAT mtDNA was low and was further decreased by stavudine. In conclusion, stavudine can decrease hepatic and muscle mtDNA in lean mice and can also cause ketoacidosis during fasting without altering mtDNA. Stavudine depletes WAT mtDNA only in obese mice. Fasting and ketoacidosis could trigger decompensation in patients with incipient lactic acidosis, whereas WAT mtDNA depletion could cause lipodystrophy in genetically susceptible patients.
AuthorsI Gaou, M Malliti, M C Guimont, P Lettéron, C Demeilliers, G Peytavin, C Degott, D Pessayre, B Fromenty
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 297 Issue 2 Pg. 516-23 (May 2001) ISSN: 0022-3565 [Print] United States
PMID11303038 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-HIV Agents
  • DNA, Mitochondrial
  • Fatty Acids
  • Reactive Oxygen Species
  • Thiobarbituric Acid Reactive Substances
  • DNA
  • Stavudine
Topics
  • Animals
  • Anti-HIV Agents (blood, pharmacology)
  • Citric Acid Cycle (drug effects)
  • DNA (biosynthesis, isolation & purification)
  • DNA, Mitochondrial (drug effects)
  • Fatty Acids (metabolism)
  • Genome
  • Immunoblotting
  • Lipid Metabolism
  • Mice
  • Mice, Inbred ICR
  • Mitochondria (drug effects)
  • Nucleic Acid Hybridization
  • Obesity (genetics, metabolism)
  • Oxidation-Reduction
  • Oxygen Consumption
  • Reactive Oxygen Species (metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stavudine (blood, pharmacology)
  • Thiobarbituric Acid Reactive Substances (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: